Gain Therapeutics Announces Preclinical Data Showing Restoration of Enzymatic Function with Novel Allosteric Regulators in GM1 Gangliosidosis Model

December 15, 2023

https://www.globenewswire.com/news-release/2023/12/01/2789279/0/en/Gain-Therapeutics-Announces-Preclinical-Data-Showing-Restoration-of-Enzymatic-Function-with-Novel-Allosteric-Regulators-in-GM1-Gangliosidosis-Model.html

Compounds significantly restored β-Gal function and reduced intracellular toxic substrates in model of GM1 gangliosidosis

Results published in PLOS ONE in collaboration with Institute for Research in Biomedicine

Read more at globenewswire.com

Related news for (GANX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.